Skip to main content
. 2022 Jun 14;61(6):789–817. doi: 10.1007/s40262-022-01125-2

Fig. 3.

Fig. 3

Special populations in which linezolid therapeutic drug monitoring (TDM) may be warranted. Created with BioRender.com